Okawaki Makoto 岡脇誠

… Alternative Names

岡脇誠オカワキマコト

Less

Researcher Number	40509254
Other IDs
Affiliation (Current)	2025: 川崎医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2025: 川崎医科大学, 医学部, 講師 2020 – 2023: 川崎医科大学, 医学部, 講師
Review Section/Research Field	Except Principal Investigator Basic Section 55050:Anesthesiology-related / Medium-sized Section 90:Biomedical engineering and related fields / Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 52010:General internal medicine-related
Keywords	Except Principal Investigator メチル化 / 痛覚変調性疼痛 / 神経障害性疼痛 / 侵害受容性疼痛 / 変形性関節症 / マイクロRNA / 脱メチル化 / 癌免疫 / 癌性腹膜炎 / 新規養子免疫細胞療法 … More / 脱メチル化剤 / 難治性癌性腹水 / 免疫療法 / エピゲノム / 薬物療法 / 免疫チェックポイント阻害剤 / バイオマーカー / 胃癌 / サイトカイン / DNAメチル化 / せん妄 Less

血漿中マイクロRNAプロファイリングによる疼痛評価
- Principal Investigator
  
  西江宏行
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55050:Anesthesiology-related
- Research Institution
  Kawasaki Medical School
Construction of epigenetic biomarkers by regenerative indices of immune function
- Principal Investigator
  
  Tanioka Hiroaki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Kawasaki Medical School
Development of a new strategy to treat cancerous peritonitis
- Principal Investigator
  
  Nagasaka Takeshi
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 90:Biomedical engineering and related fields
- Research Institution
  Kawasaki Medical School
Deep learningを用いたせん妄発症高リスク群予測モデルの構築
- Principal Investigator
  
  佐野史典
- Project Period (FY)
  2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52010:General internal medicine-related
- Research Institution
  Kawasaki Medical School

All 2023 2022 2021

All Journal Article Presentation

[Journal Article] Neutrophil and lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer.2023
- Author(s)
  Tanioka H, Okawaki M, Yano S, Yoshimitsu T, Tokuda K, Nyuya A, Yamaguchi Y, Nagasaka T.
- Journal Title
  
  Oncol Lett.
  
  Volume: 25 Issue: 3 Pages: 98-98
- DOI
  10.3892/ol.2023.13684
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K16474, KAKENHI-PROJECT-19K07787, KAKENHI-PROJECT-21K07185
[Journal Article] Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations.2021
- Author(s)
  Kawai T, Nyuya A, Mori Y, Tanaka T, Tanioka H, Yasui K, Toshima T, Taniguchi F, Shigeyasu K, Umeda Y, Fujiwara T, Okawaki M, Yamaguchi Y, Goel A, Nagasaka T.
- Journal Title
  
  Clin Epigenetics.
  
  Volume: 13 (1) Issue: 1 Pages: 117-117
- DOI
  10.1186/s13148-021-01104-7
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09217, KAKENHI-PROJECT-19K07787, KAKENHI-PROJECT-20K09110, KAKENHI-PROJECT-21K07185, KAKENHI-PROJECT-21K19934
[Journal Article] Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer.2021
- Author(s)
  Taniguchi F, Nyuya A, Toshima T, Yasui K, Mori Y, Okawaki M, Kishimoto H, Umeda Y, Fujiwara T, Tanioka H, Yamaguchi Y, Goel A, Nagasaka T.
- Journal Title
  
  Future Sci OA.
  
  Volume: 7 (10) Issue: 10
- DOI
  10.2144/fsoa-2021-0059
- NAID
  120007170517
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K09217, KAKENHI-PROJECT-19K07787, KAKENHI-PROJECT-20K09110, KAKENHI-PROJECT-21K07185, KAKENHI-PROJECT-21K19934
[Presentation] Pre-treatment PD-1 lymphocyte ratio in blood may predict clinical outcome of gastric cancer patients under Nivolumab monotherapy2023
- Author(s)
  Hiroaki Tanioka, Takeshi Nagasaka, Shuya Yano, Makoto Okawaki, Masahiro Yamamura, Yoshiyuki Yamaguchi
- Organizer
  第20回日本臨床腫瘍学会
- Data Source
  KAKENHI-PROJECT-21K07185
[Presentation] Pre-treatment PD-1 lymphocyte ratio in blood may predict clinical outcome of gastric cancer patients under Nivolumab monotherapy2023
- Author(s)
  Hiroaki Tanioka, Takeshi Nagasaka, Shuya Yano, Makoto Okawaki, Masahiro Yamamura, Yoshiyuki Yamaguchi
- Organizer
  第20回日本臨床腫瘍学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07185
[Presentation] Wnt signaling cascadeにおける低メチル化を特徴とするGenomically stable 胃癌2022
- Author(s)
  谷岡洋亮, 安井和也, 母里淑子, 田中健大, 木村圭介, 入谷光洋, 岡脇誠, 矢野修也, 山口佳之, 永坂岳司
- Organizer
  第60回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07185
[Presentation] 胃癌ニボルマブ投与による末梢血 PD1CD8 陽性 T リンパ球変化は効果予測となりうる2021
- Author(s)
  谷岡洋亮, 永坂岳司, 堅田洋佑, 岡脇誠, 山村真宏, 山口佳之
- Organizer
  第 59 回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-21K19934
[Presentation] 胃癌薬物療法における投与前低好中球リンパ球比は良好な予後予測因子となりうる2021
- Author(s)
  谷岡洋亮、永坂岳司、堅田洋佑、佐野史典、岡脇誠、山村真弘、山口佳之
- Organizer
  第43回日本癌局所療法研究会
- Data Source
  KAKENHI-PROJECT-21K07185
[Presentation] 胃癌ニボルマブ投与による末梢血PD1CD8陽性Tリンパ球変化は効果予測となりうる2021
- Author(s)
  [演者] 谷岡洋亮:1 [共同演者] 永坂岳司:1, 堅田洋佑:1, 岡脇誠:1, 山村真宏:1, 山口佳之:1
- Organizer
  第59回日本癌治療学会学術集会
- Data Source
  KAKENHI-PROJECT-21K07185

1. Nagasaka Takeshi (30452569)

# of Collaborated Projects: 4 results

# of Collaborated Products: 8 results
2. Tanioka Hiroaki (40775491)

# of Collaborated Projects: 3 results

# of Collaborated Products: 6 results
3. 佐野史典 (60435013)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 山口佳之 (10230377)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. 矢野修也 (50794624)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 西江宏行 (20379788)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 作田由香 (50509370)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. UMEDA Yuzo

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
9. 藤原俊義

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
10. 重安邦俊

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Okawaki Makoto 岡脇 誠

岡脇 誠 オカワキ マコト

Research Projects

Research Products

Co-Researchers

血漿中マイクロRNAプロファイリングによる疼痛評価

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Construction of epigenetic biomarkers by regenerative indices of immune function

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new strategy to treat cancerous peritonitis

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Deep learningを用いたせん妄発症高リスク群予測モデルの構築

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Neutrophil and lymphocyte ratio before each chemotherapy line predicts clinical outcomes in patients with unresectable gastric cancer.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer.2021

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] Pre-treatment PD-1 lymphocyte ratio in blood may predict clinical outcome of gastric cancer patients under Nivolumab monotherapy2023

Author(s)

Organizer

Data Source

[Presentation] Pre-treatment PD-1 lymphocyte ratio in blood may predict clinical outcome of gastric cancer patients under Nivolumab monotherapy2023

Author(s)

Organizer

Data Source

[Presentation] Wnt signaling cascadeにおける低メチル化を特徴とするGenomically stable 胃癌2022

Author(s)

Organizer

Data Source

[Presentation] 胃癌ニボルマブ投与による末梢血 PD1CD8 陽性 T リンパ球変化は効果予測となりうる2021

Author(s)

Organizer

Data Source

[Presentation] 胃癌薬物療法における投与前低好中球リンパ球比は良好な予後予測因子となりうる2021

Author(s)

Organizer

Data Source

[Presentation] 胃癌ニボルマブ投与による末梢血PD1CD8陽性Tリンパ球変化は効果予測となりうる2021

Author(s)

Organizer

Data Source

Okawaki Makoto 岡脇誠

岡脇誠オカワキマコト